18F- 18F-LABELED COMPOUNDS FOR DIAGNOSIS OF PROSTATE CANCER AND USE THEREOF

The present invention relates to an 18F-labeled compound and uses thereof. The above compound has a characteristic of being selectively bound to a prostate-specific membrane antigen (PSMA), and can be used in positron emission tomography (PET) to obtain a prostate cancer image in a short time. 본 발명은...

Full description

Saved in:
Bibliographic Details
Main Authors LIM, SANG MOO, LEE, KYO CHUL, CHU SO YOUNG, CHI DAE YOON, MOON, HEE JUNG, KIM, MIN HWAN, JEONG, HYEON JIN, YANG, SUNG UK, YOO, RAN JI, PARK, JI AE, JUNG, WOON JUNG, LEE, YONG JIN, KIM, MI HYUN, LEE BYOUNG SE
Format Patent
LanguageEnglish
Korean
Published 28.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to an 18F-labeled compound and uses thereof. The above compound has a characteristic of being selectively bound to a prostate-specific membrane antigen (PSMA), and can be used in positron emission tomography (PET) to obtain a prostate cancer image in a short time. 본 발명은F-표지된 화합물 및 그의 용도에 관한 것이다. 상기의 화합물은 전립선특이 세포막항원(Prostate-Specific Membrane Antigen, PSMA)에 선택적으로 결합하는 특징이 있으며, 양전자방출 단층촬영술(Positron Emission Tomography, PET)에 사용하여 전립선암 영상을 단시간 내에 선명하게 취득할 수 있다.
Bibliography:Application Number: KR20180069590